Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

Bullboard (TSX:LABS)

View:
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
Comment by subaru1on Jul 08, 2024 1:20pm

RE:The stock price will not sustain another

I am expecting a very little positiv EBITDA that's about it. Little bit of invrease in the revenue and gros profit with a reduction of the Administration from ovr 4 milliond to 1 million.
19
Discussion
Post by pidukson Jul 08, 2024 1:09pm

The stock price will not sustain another

failure when earnings announced in mid August from Q2 activity.   Will it go to $.01 ?
33
Discussion
Comment by corvette67on Jul 08, 2024 12:20pm

RE:Strong product position....

Its diversified revenue stream and strong Canadian base have got it up to $.07. LOL GLTA
14
Discussion
Post by subaru1on Jul 08, 2024 12:16pm

Last calendar about rescheduling from 1 to 3

Timeline for Implementation Key dates include: May 21, 2024: Publication of the proposed rescheduling draft ruling (PRDR) in the Federal Register and the start of a 60-day public comment period ...more  
35
Post by subaru1on Jul 08, 2024 10:43am

TD

is totally controling the market today as of lately.
30
Post by subaru1on Jul 08, 2024 10:41am

Research and development

Pharmaceutical and Business to Business (“B2B”): This stream includes the production and sale of bulk cannabis concentrate based products such as dronabinol, concentrate, distillate and isolate to ...more  
49
Post by proneon Jul 08, 2024 8:19am

Strong product position....

Specializing in the research-driven development and manufacturing of cannabis API, the company has diversified its revenue portfolio and operates with a strong Canadian base. Their CBD dominant oil ...more  
92
Discussion
Comment by subaru1on Jul 07, 2024 1:49pm

RE:Headset data.

It is positive but that shows very small revenue.
21
Discussion
Comment by QContinuum1on Jul 05, 2024 12:38pm

RE:Headset data.

Appears positive certainly.  What comes of the positivity, who knows.
36
Discussion
Post by alleyesonmeon Jul 05, 2024 11:43am

Headset data.

https://www.headset.io/brands/medipharm-labs
105
Discussion
Post by pidukson Jul 05, 2024 10:20am

Dave, you won't tell them that and make the

shareholders wait, so FU, the news is out.  Sue me you POS.  And think twice before you cross the border if they let you in. 
58
Post by pidukson Jul 05, 2024 10:18am

3rd drug approval completes the package for Apotex

2 Brazil, generic Epidiolex pending FDA.   Parrot Dave, a real POS. 
68
Comment by Starkickeron Jul 04, 2024 9:13pm

RE:Blatant lie in less than 6 months?

Ed, calm down. Athea needs to give you your meds.And you're not fooling anybody with your new handle and persona. It looks like this stock has sent you and Alleyesonme to the asylum. It is amazing ...more  
86
Discussion
Post by pidukson Jul 04, 2024 6:46pm

How stupid is stupid? Like a broken parrot talking

of 'mergers and acquisitions' instead of giving shareholder clarity of generic Epidiolex launch and the company bleeding red ink at the bottom line.   He is an IDIOT sales rep that ...more  
77
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

Dealroom for high-potential pre-IPO opportunities